Burden of peripheral arterial disease in Europe and the United States: A patient survey

Health and Quality of Life Outcomes

Volumn 11, Issue 1, 2013, Pages

  Marrett, Elizabeth ^a   DiBonaventura, Marco D ^b   Zhang, Qiaoyi ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b KANTAR HEALTH   (United States)

Author keywords

Health related quality of life; Healthcare resource use; Peripheral arterial disease; Work productivity and activity impairment

Indexed keywords

ABSENTEEISM; ADULT; AGE; ARTHRITIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; COMORBIDITY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EMERGENCY WARD; EXERCISE; FEMALE; FRANCE; GASTROINTESTINAL DISEASE; GERMANY; HEALTH CARE UTILIZATION; HEALTH STATUS; HEALTH SURVEY; HEART INFARCTION; HOSPITALIZATION; HUMAN; INFECTION; INTERNET; ITALY; KIDNEY DISEASE; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEOPLASM; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSICIAN; PRODUCTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; SELF REPORT; SMOKING; SPAIN; UNITED KINGDOM; UNITED STATES; WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; EFFICIENCY; EUROPE; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; QUALITY OF LIFE; QUESTIONNAIRES; UNITED STATES; WORK; YOUNG ADULT;

EID: 84886937347     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-11-175     Document Type: Article

References (30)

1. Olin JW, Sealove BA. Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc 2010, 85:678-692. 10.4065/mcp.2010.0133, 2894725, 20592174.
2. Ouriel K. Peripheral arterial disease. Lancet 2001, 358:1257-1264. 10.1016/S0140-6736(01)06351-6, 11675083.
3. Dawson DL, Hagino RT. Critical limb ischemia. Curr Treat Options Cardiovasc Med 2001, 3:237-249. 10.1007/s11936-001-0042-5, 11341869.
4. Caro J, Migliaccio-Walle K, Ishak KJ, Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 2005, 5:14. 10.1186/1471-2261-5-14, 1183197, 15972099.
5. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743. 10.1161/01.CIR.0000137913.26087.F0, 15262830.
6. Ramos R, Quesada M, Solanas P, Subirana I, Sala J, Vila J, Masiá R, Cerezo C, Elosua R, Grau M, Cordón F, Juvinyà D, Fitó M, Isabel Covas M, Clarà A, Angel Muñoz M, Marrugat J, . REGICOR Investigators Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009, 38:305-311. 10.1016/j.ejvs.2009.04.013, 19515589, REGICOR Investigators.
7. Alzamora MT, Forés R, Baena-Díez JM, Pera G, Toran P, Sorribes M, Vicheto M, Reina MD, Sancho A, Albaladejo C, Llussà J, . PERART/ARTPER study group The peripheral arterial disease study (PERART/ARTPER): prevalence and risk factors in the general population. BMC Public Health 2010, 10:38. 10.1186/1471-2458-10-38, 2835682, 20529387, PERART/ARTPER study group.
8. Pujia A, Gnasso A, Mancuso G, Spagnuolo M, Cosco C, Cortese C, Colonna A, Mattioli PL. Asymptomatic arteriopathy of the lower limbs. Prevalence and risk factors in a population of southern Italy [Italian]. Minerva Cardioangiol 1993, 41:133-138.
9. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991, 20:384-392. 10.1093/ije/20.2.384, 1917239.
10. Kruidenier LM, Nicolaï SP, Willigendael EM, de Bie RA, Prins MH, Teijink JA. Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication. BMC Cardiovasc Disord 2009, 9:9. 10.1186/1471-2261-9-9, 2667172, 19254382.
11. Izquierdo-Porrera AM, Gardner AW, Bradham DD, Montgomery PS, Sorkin JD, Powell CC, Katzel LI. Relationship between objective measures of peripheral arterial disease severity to self-reported quality of life in older adults with intermittent claudication. J Vasc Surg 2005, 41:625-630. 10.1016/j.jvs.2005.01.012, 15874926.
12. Tretinyak AS, Lee ES, Kuskowski MM, Caldwell MP, Santilli SM. Revascularization and quality of life for patients with limb-threatening ischemia. Ann Vasc Surg 2001, 15:84-88.
13. Leicht AS, Crowther RG, Muller R, Golledge J. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. Eur J Vasc Endovasc Surg 2011, 41:511-517. 10.1016/j.ejvs.2010.12.018, 21247784.
14. Margolis J, Barron JJ, Grochulski WD. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm 2005, 11:727-734.
15. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG, Cohen DJ, Steg G, Bhatt DL, Hirsch AT, . Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes 2010, 3:642-651. 10.1161/CIRCOUTCOMES.109.930735, 20940249, Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators.
16. Smolderen KG, Wang K, de Pouvourville G, Brüggenjürgen B, Röther J, Zeymer U, Parhofer KG, Steg PG, Bhatt DL, Magnuson EA, . REACH Registry Investigators Two-year vascular hospitalisation rates and associated costs in patients at risk of atherothrombosis in France and Germany: highest burden for peripheral arterial disease. Eur J Vasc Endovasc Surg 2012, 43:198-207. 10.1016/j.ejvs.2011.09.016, 22001145, REACH Registry Investigators.
17. Aronow WS. Management of peripheral arterial disease. Cardiol Rev 2005, 13:61-68. 10.1097/01.crd.0000126082.86717.12, 15705252.
18. Duggan MM, Woodson J, Scott TE, Ortega AN, Menzoian JO. Functional outcomes in limb salvage vascular surgery. Am J Surg 1994, 168:188-191. 10.1016/S0002-9610(94)80065-0, 8053524.
19. Chetter IC, Spark JI, Scott DJ, Kent PJ, Berridge DC, Kester RC. Prospective analysis of quality of life in patients following infrainguinal reconstruction for chronic critical ischaemia. Br J Surg 1998, 85:951-955. 10.1046/j.1365-2168.1998.00752.x, 9692571.
20. Bosch JL, van der Graaf Y, Hunink MG. Health-related quality of life after angioplasty and stent placement in patients with iliac artery occlusive disease: results of a randomized controlled clinical trial. Circulation 1999, 99:3155-3160. 10.1161/01.CIR.99.24.3155, 10377079.
21. Tangelder MJ, McDonnel J, Van Busschbach JJ, Buskens E, Algra A, Lawson JA, Eikelboom BC. Quality of life after infrainguinal bypass grafting surgery. J Vasc Surg 1999, 29:913-919. 10.1016/S0741-5214(99)70219-3, 10233784.
22. Bosch JL, Hunink MG. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making 1996, 16:217-225. 10.1177/0272989X9601600305, 8818119.
23. de Vries SO, Kuipers WD, Hunink MG. Intermittent claudication: symptom severity versus health values. J Vasc Surg 1998, 27:422-430. 10.1016/S0741-5214(98)70316-7, 9546227.
24. Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS ONE 2012, 7:e50553. 10.1371/journal.pone.0050553, 3511565, 23226312.
25. DiBonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health In press.
26. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to Score Version 2 of the SF-12® Health Survey (With a Supplement Documenting Version 1) 2002, Lincoln, RI: QualityMetric Incorporated.
27. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004, 42:851-859. 10.1097/01.mlr.0000135827.18610.0d, 15319610.
28. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993, 4:353-365. 10.2165/00019053-199304050-00006, 10146874.
29. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383. 10.1016/0021-9681(87)90171-8, 3558716.
30. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual Life Outcomes 2003, 1:4. 10.1186/1477-7525-1-4, 155547, 12737635.